QR Code
Morales-Portano, Julieta D; Angel Peraza-Zaldivar, Juan; Suarez-Cuenca, Juan A; Aceves-Millan, Rocio; Amezcua-Gomez, Lilia; Ixcamparij-Rosales, Carlos H; Trujillo-Cortes, Rafael; Robledo-Nolasco, Rogelio; Mondragon-Teran, Paul; Perez-Cabeza de Vaca, Rebeca; Hernandez-Munoz, Rolando; Melchor-Lopez, Alberto; Vannan, Mani A; Francisco Rubio-Guerra, Alberto (2018)

ECHOCARDIOGRAPHIC MEASUREMENTS OF EPICARDIAL ADIPOSE TISSUE AND COMPARATIVE ABILITY TO PREDICT ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE

Int J Cardiovasc Imaging 34(9):1429-1437
full text

The present study aimed to compare echocardiography measurements of epicardial adipose tissue (EAT) thickness and other risk factors regarding their ability to predict adverse cardiovascular outcomes in patients with coronary artery disease (CAD). Outcomes of 107 patients (86 males, 21 females, mean age 63.6 years old) submitted to diagnostic echocardiography and coronary angiography were prospectively analyzed. EAT (measures over the right ventricle, interventricular groove and complete bulk of EAT) and left ventricle ejection fraction (LVEF) were performed by echocardiography. Coronary complexity was evaluated by Syntax score. Primary endpoints were major adverse cardiovascular events (MACE's), composite of cardiovascular death, myocardial infarction, unstable angina, intra-stent re-stenosis and episodes of decompensate heart failure requiring hospital attention during a mean follow up of 15.94 ± 3.6 months. Mean EAT thickness was 4.6 ± 1.9 mm; and correlated with Syntax score and body mass index; negatively correlated with LVEF. Twenty-three cases of MACE's were recorded during follow up, who showed higher EAT. Diagnostic ability of EAT to discriminate MACE's was comparable to LVEF (AUROC > 0.5); but higher than Syntax score. Quartile comparison of EAT revealed that measurement of the complete bulk of EAT provided a better discrimination range for MACE's, and higher, more significant adjusted risk (cutoff 4.6 mm, RR = 3.91; 95% CI 1.01-15.08; p = 0.04) than the other risk factors. We concluded that echocardiographic measurement of EAT showed higher predicting ability for MACE's than the other markers tested, in patients with CAD. Whether location for echocardiographic measurement of EAT impacts the diagnostic performance of this method deserves further study.